ГОСТ ISO 10993-16-2016
[25] KWON, Y. (ed), Handbook of essential pharmacokinetics, pharmacodynamics and
drug metabolism for industrial scientists, Springer Verlag, 2001
[26] HANSCH, C„ MEKAPATI, S.B., KURUP, A. and VERMA, R.P., QSAR of
Cytochrome P450, Drug Metab. Revs., 36, pp. 105-156,2004
[27] Harmonised Tripartite Guideline — Note for Guidance on Toxicokinetics: The
Assessment of Systemic Exposure in Toxicity Studies, ICH S3A, 1994
[28] Harmonised Tripartite Guideline — Pharmacokinetics: Guidance for Repeated
Dose Tissue Distribution Studies, ICH S3B.1994
[29] HEDAYA, M.A., Basic pharmacokinetics. CRC Press pharmacy education series,
CRC Press, Boca Raton,FL, 2007
[30] HEINONEN, M., OILA, O. and NORDSTROM, K., Current issues in the regulation
of human tissueengineering products in the European Union,Tissue Eng., 11, pp.
1905-1911,2005
[31] HENGSTLER, J.G., et aI., Cryopreserved primary hepatocytes as a constantly
available in vitro model for the evaluation of human and animal drug metabolism
and enzyme induction. Drug Metab. Revs., 32, pp. 81-118,2000
[32] HOUSTON, J.B. and GALETIN, A., Progress towards prediction of human
pharmacokinetic parameters from in vitro technologies, Drug Metab. Revs., 35,
pp. 393-415,2003
[33] GUENGERICH, F.P. and RENDIC, S., (eds), Human cytochrome P450 enzymes,
a status report summarizing their reactions, substrates, inducers and inhibitors -
1st update. Special issue on Human cytochromes P450 (Human CYPs), Drug
Metab. Revs., 34, pp. 1-450, 2002
[34] Human cytochrome P450s: assessment, regulation and genetic polymorphisms,
Xenobiotica (special issue), 28, pp. 1093-1291,1998
[35] ICH S3A Toxicokinetic guidancereference — Note for Guidanceon
Toxicokinetics: A Guidance for Assessing Systemic Exposure in Toxicity Studies
(СPMP/1СH/384/95.)
[36] International Programme On Chemical Safety. Environmental Health Criteria 57:
Principles oftoxicokinetic studies, World Health Organization, Geneva, 1986
[37] TOZER, T.N. and ROWLAND, M. (eds)., Introduction to pharmacokinetics and
pharmacodynamics: the quantitative basis of drug therapy, Lippincott, Williams &
Wilkins, 2006
[38] KEEGAN, G.M., LEARMONTH, I.D. and CASE, C.P., Orthopaedic metals and
17